-
Artificial intelligence could help work out the best diet for every individual
CNN — Is broccoli or beetroot the best option for your personal health? Which foods are likely to trigger the biggest glucose spikes or cholesterol surges in your blood? Custom diets are the next frontier in nutrition science – and artificial intelligence (AI) will play a key role in figuring out what each of us should, and shouldn’t, be eating. An ambitious program called Nutrition for Precision Health (NPH) kicked off in the US in January 2022 when the National Institutes of Health (NIH) awarded $170 million to fund institutions across the country to conduct a five-year study with 10,000 participants. CNN spoke to Holly Nicastro, program director in the…
-
Artificial intelligence and its potential to change healthcare
A panel of physicians and leaders in the field expressed enthusiasm for AI’s possible benefits for patients. They also said solutions must be designed with health equity in mind. Many have hailed the potential of artificial intelligence to transform healthcare. Michael Howell, Google’s chief clinical officer and deputy chief health officer, says, “It’s hard to imagine a technology that is more hyped than AI.” Even so, Stephen Parodi, executive vice president of The Permanente Federation, says, “Widespread AI use in healthcare is still in its infancy.” Still, many are projecting significant growth in the prevalence of AI in medicine in the near future. During a one-hour forum hosted by The…
-
USF Health, Weill Cornell Medicine Earn Inaugural Funding in NIH’s Newly Launched Bridge2AI Initiative, will Create Artificial Intelligence Platform for Using
Tampa FL (Sept. 13, 2022) – Artificial intelligence may soon help doctors diagnose and treat diseases, including cancer and depression, based on the sound of a patient’s voice, as 12 leading research institutions launch a landmark National Institutes of Health-funded academic project that may establish voice as a biomarker used in clinical care. The University of South Florida in Tampa, FL, is the lead institution on the project in collaboration with WeillCornell Medicine in New York City, 10 other institutions in the United States and Canada, and French-American AI biotech startup Owkin. The first year of the project includes $3.8 million from the NIH, with subsequent funding over the following…
